Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biote Corp BTMD

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that... see more

Recent & Breaking News (NDAQ:BTMD)

Biote Announces Strategic Partnership with IMAC Holdings, Inc.

GlobeNewswire September 7, 2022

Biote Announces Approval to Relist on The Nasdaq Stock Market

Business Wire August 25, 2022

Biote Appoints Samar Kamdar as Chief Financial Officer

Business Wire August 24, 2022

Biote Issues Correction to Second Quarter Operating Loss and Net Income

Business Wire August 15, 2022

Biote Reports Second Quarter 2022 Financial Results

Business Wire August 9, 2022

Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022

Business Wire July 20, 2022

Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer

Business Wire June 16, 2022

Biote Announces Participation in the Jefferies Healthcare Conference 2022

Business Wire June 6, 2022

National Women in the Workplace Survey: Women with Menopausal Symptoms Suffer in Silence in the Workplace

Business Wire June 6, 2022

Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry

Business Wire May 26, 2022

Haymaker Acquisition Corp. III Announces Stockholder Approval of Business Combination with Biote

GlobeNewswire May 24, 2022

Haymaker Acquisition Corporation III Reminds Shareholders to Vote in Favor of the Proposed Business Combination with Biote Before May 24

GlobeNewswire May 17, 2022

Biote Reports First Quarter 2022 Financial Results and Provides Corporate Update

Business Wire May 11, 2022

Biote Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook

GlobeNewswire March 22, 2022

Haymaker Acquisition Corp. III Announces the Separate Trading of Its Class A Common Stock and Redeemable Warrants Commencing April 22, 2021

GlobeNewswire April 19, 2021

Haymaker Acquisition Corp. III Announces Closing of $300 Million Initial Public Offering

GlobeNewswire March 4, 2021

Haymaker Acquisition Corp. III Announces Pricing of $300 Million Initial Public Offering

GlobeNewswire March 1, 2021

Haymaker Acquisition Corp. II, ARKO Holdings Ltd. and GPM Investments, LLC Close Business Combination under New Company ARKO Corp.

GlobeNewswire December 22, 2020

ARKO / GPM and Haymaker Acquisition Corp. II Announce Business Updates

GlobeNewswire November 19, 2020

ARKO / GPM Unveils Plans for its Store Prototype of the Future

GlobeNewswire November 19, 2020